期刊文献+

芳香化酶细胞色素P450在子宫内膜异位症中的检测与临床意义 被引量:5

The Expression and Significance of Aromatase Cytochrome P450 in Endometrium from Women with Endometriosis
下载PDF
导出
摘要 目的:探讨芳香化酶细胞色素P450(P450arom)在子宫内膜异位症(EM)患者子宫内膜中的表达及临床意义。方法:采用免疫组织化学方法检测63例EM患者、40例妇科良性疾病患者及30例正常对照组患者子宫内膜中P450arom蛋白的表达,并结合EM患者的临床分期等进行比较分析。结果:P450arom蛋白在正常对照组子宫内膜中无表达;在良性疾病对照组中阳性检出率为17.50%(7/40),表达水平(0.22±0.16);在EM患者子宫内膜中阳性检出率为81%,表达水平(0.57±0.26),差异有统计学意义(P<0.05)。P450arom蛋白表达在增生期与分泌期差异无统计学意义(P>0.05)。P450arom蛋白表达随EM临床分期增加呈增强趋势,但差异无统计学意义(r=0.226,P>0.05)。结论:P450arom在EM患者子宫内膜中的高表达与EM的发生有关;检测P450arom蛋白在子宫内膜的表达可作为诊断EM新的参考指标。 Objective:To investigate the expression and clinical significance of aromatase cytochrome P450(P450arom) in endometrium of endometriosis patients.Methods:The expression of P450arom was examined by immunohistochemistry in endometrium of 63 patients with endometriosis,40 patients with benign gynecologic diseases and 30 normal control women.Results:The positive expression rate of P450arom was 0 in normal endometrium tissues,17.50% in tissues of benign gynecologic diseases(0.22±0.16) and 80.95% in endometriosis with the expression level of 0.57±0.26(P 0.05).The expression of P450arom was not related to the menstrual periods,which were proliferative phase and secretory phase(P 0.05).The expression of P450arom was enhanced with the clinical stage,but there was no statistic significance(r = 0.226,P 0.05).Conclusion:The higher-expression of P450arom in endometrium was related to the development of endometriosis.The expression of P450arom may be one of parameters for understanding the endometriosis.
出处 《天津医药》 CAS 北大核心 2010年第12期1050-1052,共3页 Tianjin Medical Journal
关键词 芳香酶 子宫内膜异位症 细胞色素P450酶系统 免疫组织化学 子宫肿瘤 卵巢肿瘤 aromatase endometriosis cytochrome P-450 enzyme system immunohistochemistry uterine neoplasms ovarian neoplasms
  • 相关文献

参考文献9

  • 1Revised A.American Fertility Society Classification of Endometriosis:1985[J].Fertil Steril,1985,43(2):351-354.
  • 2韩永,徐燕杰.病理图像分析系统在临床病理和科研中的应用[J].国外医学(临床生物化学与检验学分册),2003,24(2):118-119. 被引量:7
  • 3田玉英,惠京.芳香化酶与子宫内膜异位症[J].国外医学(妇产科学分册),2007,34(1):37-40. 被引量:3
  • 4朱兰,谭先杰.第二次全国子宫内膜异位症专题学术会议纪要[J].中华妇产科杂志,2006,41(10):652-655. 被引量:32
  • 5Bulun SE,Fang Z,Imir G,et al.Aromatase and endometriosis[J].Semin Reprod Med,2004,22(1):45-50.
  • 6Ishihara H,Kitawaki J,Kado N.et al.Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450expression in eutopic endometrium from women with endometriosis,adenomyosis,or leiomyomas[J].Fertil Steril,2003,79(Suppl 1):735-742.
  • 7Dheenadayalu K,Mak I,Gordts S.et al.Aromatase P450 messenger RNA expression in eutopic endometrium is not a specific maker for pelvic endometriosis[J].Fertil Sterii,2002,78(4):825-829.
  • 8Tamura M,Deh S,Sebastian S,et al.Estrogen up-regulates cyclooxygenase-2 via estrogen receptor in human uterin mierovascular endothelial cells[J].Fertil Steril,2004,81(5):1351-1356.
  • 9Oha H,Igarashi S,Saski M,et al.Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis[J].Hum Reprod,2001,16(3):561-566.

二级参考文献20

  • 1Gurates B,Bulun SE.Endometriosis:the ultimate hormonal disease[J].Semin Reprod Med,2003,21 (2):125-134.
  • 2Graddy LG,Kowalski AA,Stimmen FA,et al.Multiple isoforms of porcine aromatase are encoded by three distinct genes[J].J Steroid Biochem Mol Biod,2000,73 (1-2):49-57.
  • 3Bulun SE,Noble LS,Takayama K,et al.Endocrine disorders associated with inappropriately high aromatase expression[J].J Steroid Biochem Mol Biol,1997,61 (3 ~6):133-139.
  • 4Nelson LR,Bulun SE.Estrogen production and action[J].J Am Acad Dermatol,2001,45[Suppl 3]:S116-124.
  • 5Kitawaki J,Noguchi T,Amatsu T,et al.Expression of aromatase cytochrome P450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissues but not in normal endometrium[J].Biol Reprod,1997,57(3):514-519.
  • 6Kitawaki J,Kusuki I,Koshiba H,et al.Detection of aromatase cytochrome P-450 in endometrial biopsy specimens as a diagnostic test for endometriosis[J].Fertil Steril,1999,72 (6):1100-1106.
  • 7Ishihara H,Kitawaki J,Kado N,et al.Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P-450expression in eutopic endometrium fromwomen with endometriosis,adenomyosis,or leiomyomas[J].Fertil Steril,2003,79[Suppl 1]:735-742.
  • 8Johnson MC,Pinto C,Alves A,et al.P450 Arom and estrogenic microenvironment of eutopic endometria in endometriosis[J].Rev Med Chil,2004,132(12):1475-1482.
  • 9Heilier JF,Donnez O,Van Kerckhove V,et al.Expression of aromatase (P450 aromatase/CYP19) in peritoneal and ovarian endometriotic tissues and deep endometriotic (adenomyotic) nodules of the rectovaginal septum[J].Fertil Steril,2006,85 (5):1516-1518.
  • 10Matsuzaki S,Canis M,Pouly JL,et al.Analysis of aromatase and 17beta-hydroxysteroid dehydrogenase type 2 messenger ribonucleic acid expression in deep endometriosis and eutopic endometrium using laser capture microdissection[J].Fertil Steril,2006,85 (2):308-313.

共引文献39

同被引文献41

引证文献5

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部